Fragile X Syndrome Research Today is a free monthly online journal that collates and summarizes the latest research about Fragile X Syndrome, including details on symptoms, treatment, heritability, diagnosis.

Volume 6 (2010), Issue 5 (May)

1. Potassium bromate, a potent DNA oxidizing agent, exacerbates germline repeat expansion in a fragile X premutation mouse model.
   Hum Mutat, 31(5): 611-6. [Abstract] [Full-text]
2. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2.
   Neuron, 66(2): 191-7. [Abstract] [Full-text]
3. A unified rapid PCR method for detection of normal and expanded trinucleotide alleles of CAG repeats in huntington chorea and CGG repeats in fragile X syndrome.
   Mol Biotechnol, 45(2): 150-4. [Abstract] [Full-text]
4. Premature ovarian failure and FMR1 gene mutations: an update.
   Ann Endocrinol (Paris), 71(3): 215-7. [Abstract] [Full-text]
5. Clinical report: a male with Down syndrome, fragile X syndrome, and autism.
   J Dev Behav Pediatr, 31(4): 333-7. [Abstract] [Full-text]
6. Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA.
   Neuropsychopharmacology, 35(7): 1500-9. [Abstract] [Full-text]
7. Relationships between early gestures and later language in children with fragile X syndrome.
   Am J Speech Lang Pathol, 19(2): 135-42. [Abstract] [Full-text]
8. Partners in crime: bidirectional transcription in unstable microsatellite disease.
   Hum Mol Genet, 19: R77-82. [Abstract] [Full-text]
9. Region-specific alterations in brain development in one- to three-year-old boys with fragile X syndrome.
   Proc Natl Acad Sci U S A, 107(20): 9335-9. [Abstract] [Full-text]
10. Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
11. Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys.
    Am J Med Genet A, 152(6): 1420-7. [Abstract] [Full-text]

© 2005-2012 Fragile X Syndrome Research Today. All Rights Reserved.